OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Clinical trial NCT04314934 · COMPLETED

Trial details

NCT number: NCT04314934
Sponsor: Anavex Life Sciences Corp.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-10-10
Primary completion: 2024-06-14
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.